2006•Chinese Journal of Critical Care MedicineRequires access

Effect of losartan and metoprolol on heart function in aged severe chronic heart failure

FU Ya

Open publisher page 0 citations

Abstract

Objective To investigate the therapeutic effect of early metoprolol combination on losartan treated gerontic patients with severe chronic heart failure.Method 65 cases(aged 72.5±6.9) of severe chronic heart failure with NYHA heart function grade were divided into three groups: losartan group(n=23),losartan and metoprolol combination group(n=22) and control group(n=20).All patients were followed up for 12 months,including their heart functions,LVEF by echocardiography,in hospital treatment days and times,and mortality.BNP value in the treatment of chronic heart failure was also investigated.Results After half year period,there were significant differences between combination group and losartan in BNP(P0.05),there were no differences between combination group and losartan in heart function and LVEF,but there were significant differences in heart functions and LVEF in combination group and losartan compared to control group(P0.05),also highly significant in BNP(P0.01).After a year,there were significant differences between combination group and losartan(P0.05) in heart functions and LVEF,also highly significant in BNP(P0.01) and there were also highly significant in heart functions,BNP and LVEF in combination group and losartan compared to control group(P0.01),combination group was the lowest group of in hospital treatment days and times.Conclusions Better clinical results achieved by losartan and metoprolol combination therapy in gerontic patients with severe chronic heart failure compared to losartan therapy alone,life quality of patients also improved by the combination therapy.

About this research paper

What this paper is about

Objective To investigate the therapeutic effect of early metoprolol combination on losartan treated gerontic patients with severe chronic heart failure.Method 65 cases(aged 72.5±6.9) of severe chronic heart failure with NYHA heart function grade were divided into three groups: losartan group(n=23),losartan and metoprolol combination group(n=22) and control group(n=20).All patients were followed up for 12 months,including their heart functions,LVEF by echocardiography,in hospital treatment days and times,and mortality.BNP value in the treatment of chronic heart failure was also investigated.Results After half year period,there were significant differences between combination group and losartan in BNP(P0.05),there were no differences between combination group and losartan in heart function and LVEF,but there were significant differences in heart functions and LVEF in combination group and losartan compared to control group(P0.05),also highly significant in BNP(P0.01).After a year,there were significant differences between combination group and losartan(P0.05) in heart functions and LVEF,also highly significant in BNP(P0.01) and there were also highly significant in heart functions,BNP and LVEF in combination group and losartan compared to control group(P0.01),combination group was the lowest group of in hospital treatment days and times.Conclusions Better clinical results achieved by losartan and metoprolol combination therapy in gerontic patients with severe chronic heart failure compared to losartan therapy alone,life quality of patients also improved by the combination therapy.

Why it matters

A significance statement is not available in the OpenAlex record.

Key contribution

A contribution statement is not available in the OpenAlex record.

Method / approach

Method details are not available in the OpenAlex metadata.

Main findings

Findings are not separately available in the OpenAlex metadata.

Limitations

Limitations are not available in the OpenAlex metadata.

Applications

Application details are not available in the OpenAlex metadata.

Available abstract

Objective To investigate the therapeutic effect of early metoprolol combination on losartan treated gerontic patients with severe chronic heart failure.Method 65 cases(aged 72.5±6.9) of severe chronic heart failure with NYHA heart function grade were divided into three groups: losartan group(n=23),losartan and metoprolol combination group(n=22) and control group(n=20).All patients were followed up for 12 months,including their heart functions,LVEF by echocardiography,in hospital treatment days and times,and mortality.BNP value in the treatment of chronic heart failure was also investigated.Results After half year period,there were significant differences between combination group and losartan in BNP(P0.05),there were no differences between combination group and losartan in heart function and LVEF,but there were significant differences in heart functions and LVEF in combination group and losartan compared to control group(P0.05),also highly significant in BNP(P0.01).After a year,there were significant differences between combination group and losartan(P0.05) in heart functions and LVEF,also highly significant in BNP(P0.01) and there were also highly significant in heart functions,BNP and LVEF in combination group and losartan compared to control group(P0.01),combination group was the lowest group of in hospital treatment days and times.Conclusions Better clinical results achieved by losartan and metoprolol combination therapy in gerontic patients with severe chronic heart failure compared to losartan therapy alone,life quality of patients also improved by the combination therapy.

Key concepts: Losartan, Medicine, Metoprolol, Heart failure, Ejection fraction, Internal medicine, Cardiology, Angiotensin II

Related papers

Back to paper searchBrowse research topicsOriginal source
Effect of losartan and metoprolol on heart function in aged severe chronic heart failure — Research Paper | ScholarLens